LakeShore Biopharma Co (LakeShore Biopharma Co) Interest Expense : $-4.32 Mil (TTM As of Sep. 2023)

View and export this data going back to 2023. Start your Free Trial

What is LakeShore Biopharma Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. LakeShore Biopharma Co's interest expense for the six months ended in Sep. 2023 was $ -2.05 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2023 was $-4.32 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. LakeShore Biopharma Co's Operating Income for the six months ended in Sep. 2023 was $ -23.11 Mil. LakeShore Biopharma Co's Interest Expense for the six months ended in Sep. 2023 was $ -2.05 Mil. LakeShore Biopharma Co did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

LakeShore Biopharma Co Interest Expense Historical Data

The historical data trend for LakeShore Biopharma Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LakeShore Biopharma Co Interest Expense Chart

LakeShore Biopharma Co Annual Data

Trend

Mar21

Mar22

Mar23

Interest Expense

-4.56

-0.43

-4.48

LakeShore Biopharma Co Semi-Annual Data
	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Interest Expense	Get a 7-Day Free Trial			-0.06	-0.37	-2.17	-2.27	-2.05

LakeShore Biopharma Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-4.32 Mil.

LakeShore Biopharma Co (NAS:LSB) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

LakeShore Biopharma Co's Interest Expense for the six months ended in Sep. 2023 was $-2.05 Mil. Its Operating Income for the six months ended in Sep. 2023 was $-23.11 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Sep. 2023 was $50.21 Mil.

LakeShore Biopharma Co's Interest Coverage for the quarter that ended in Sep. 2023 is calculated as

LakeShore Biopharma Co did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

LakeShore Biopharma Co (LakeShore Biopharma Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LakeShore Biopharma Co Ltd (NAS:LSB) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

H6Z:Germany

Address

38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629

Website

https://www.yishengbio.com

YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminium-free lyophilized rabies vaccine that was launched in China. It has one operating segment, which is the development, production, marketing and sale of biopharmaceutical products.